Associated tags: Intelligence, Patient safety, Automation, Pharmacy, Omnicell, Approximation error, Prescription, Health, Pharmaceutical, OMCL, Software, Practice Management, Hospitals, Data Management
Locations: UNITED STATES, NORTH AMERICA, TEXAS, NEVADA, NV
Hardware,
Health Technology,
Environmental, Social and Governance (ESG),
Satellite,
Technology,
Robotics,
Pharmaceutical,
Professional Services,
Philanthropy,
Medical Devices,
Hospitals,
Maritime,
Transport,
Other Philanthropy,
Health,
Mercy Ships,
Partnership,
XT,
Patient,
OMCL,
Multimedia,
Nursing Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions from the recently announced XT Amplify program.
Key Points:
- Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced continued support for the global charity Mercy Ships with the donation of solutions from the recently announced XT Amplify program.
- View the full release here: https://www.businesswire.com/news/home/20240506285986/en/
The largest non-governmental hospital fleet in the world, Mercy Ships travels to developing nations to provide sorely needed, quality healthcare for underserved patients.
- Omnicell has supported the mission of Mercy Ships through technology donations and technical support since 2017.
- “Omnicell and Mercy Ships were both founded on the idea of finding a better way,” said Kathleen Nemeth, senior vice president of Investor Relations and liaison to Mercy Ships for Omnicell.
Technology,
Health Technology,
Software,
Health,
Robotics,
Pharmaceutical,
General Health,
Retail,
Supply Chain Management,
Bank of America,
BofA Securities,
Conference,
OMCL Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT.
Key Points:
- Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the BofA Securities 2024 Health Care Conference in Las Vegs, NV, on Wednesday, May 15, 2024 at 3:40 p.m. PT.
- Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/
Satellite,
Pharmaceutical,
Hardware,
Health,
Medical Devices,
Robotics,
Health Technology,
Technology,
Pharmacy,
Introduction,
Environment,
XT,
Illuminate,
OMCL,
GAAP,
Approximation error Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2024.
Key Points:
- Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced results for its first quarter ended March 31, 2024.
- Total GAAP revenues for the first quarter of 2024 were $246 million, down $44 million, or 15%, from the first quarter of 2023.
- The Company expects second quarter 2024 product revenues to be between $140 million and $145 million, and second quarter 2024 service revenues to be between $110 million and $115 million.
- The Company expects second quarter 2024 non-GAAP EBITDA to be between $14 million and $20 million.
General Health,
Hospitals,
Health,
Pharmaceutical,
Managed Care,
Innovation,
Refrigeration,
Safety,
Hospital,
SAN,
XT,
Nursing,
Doctor of Pharmacy,
OMCL,
Multimedia,
College,
Autonomy,
Approximation error,
Online shopping Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell’s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
Key Points:
- Omnicell, Inc. (Nasdaq:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell’s XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies.
- We believe Omnicell is nicely positioned to address these current challenges while adapting for the future,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell.
- “We are confident the XT Amplify program will deliver continuous innovation that addresses these evolving and complex needs, while helping customers to maximize outcomes and the value of Omnicell automated dispensing systems currently in use around the globe.”
The solutions within the multi-year XT Amplify program are intended to enhance nursing efficiency, reduce medication errors and waste, and, ultimately, help health systems achieve the aspirational outcomes outlined in the industry-defined vision of the Autonomous Pharmacy.
- XT Amplify is intended to enable all healthcare facilities, regardless of where they are in their adoption and utilization of Omnicell’s XT Automated Dispensing System, to solve important challenges today and into the future.
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024.
Key Points:
- Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024.
- The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m.
- All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations.
- A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/ .
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m.
Key Points:
- Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024 at 4:30 p.m.
- ET.
- Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/
Retrieved on:
Thursday, February 8, 2024
Technology,
Mobile,
Wireless,
Health Technology,
Software,
Hardware,
Health,
Robotics,
Pharmaceutical,
Consumer Electronics,
Food delivery Cash flows provided by operating activities in the fourth quarter of 2023 totaled $38 million.
Key Points:
- Cash flows provided by operating activities in the fourth quarter of 2023 totaled $38 million.
- This compares to cash flows provided by operating activities totaling $82 million in the fourth quarter of 2022.
- The Company expects first quarter 2024 non-GAAP EBITDA to be between ($2) million and $4 million.
- The Company expects first quarter 2024 non-GAAP earnings per share to be between a net loss of ($0.10) and breakeven per share.
Retrieved on:
Tuesday, January 16, 2024
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on Thursday, February 8, 2024.
Key Points:
- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the fourth quarter and full year 2023, before market open on Thursday, February 8, 2024.
- The Company will host a conference call and webcast to discuss its financial results at 8:30 a.m.
- All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations.
- A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/ .
Retrieved on:
Thursday, January 11, 2024
Technology,
Specialty,
Software,
Hardware,
Pharmaceutical,
Health,
Robotics,
Supply Chain Management,
Retail,
Consumer Electronics,
Thomas Jefferson University,
Siebel Systems,
Patient,
CDK,
OMCL,
Hospital,
Multimedia,
CDK Global,
SAP,
University,
Rest,
Gartner,
Allscripts,
SAP Ariba,
Oracle,
Accenture,
Organization,
AGS,
Photograph,
Growth,
Management Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024.
Key Points:
- Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that the Board of Directors elected Eileen Voynick to the Board, effective January 5, 2024.
- White, a Class I director who stepped down from the Company’s Board of Directors, effective January 5, 2024.
- View the full release here: https://www.businesswire.com/news/home/20240111424299/en/
Omnicell Elects Eileen Voynick to Board of Directors (Photo courtesy of Omnicell, Inc.)
Ms. Voynick brings over three decades of experience driving sales and operations at global industry leaders, including in the healthcare technology industry, at the executive and board level.
- “We are pleased to welcome Eileen to the Omnicell Board of Directors,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell.
Retrieved on:
Monday, November 27, 2023
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m.
Key Points:
- Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00 p.m.
- ET.
- Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/
